Trial Outcomes & Findings for Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions (NCT NCT02137447)

NCT ID: NCT02137447

Last Updated: 2017-04-18

Results Overview

Incidence of SSIs within 1 month (4 weeks) from the index operation. SSI is defined by the Centers for Disease Control and Prevention's National Healthcare Surveillance Network

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

10 participants

Primary outcome timeframe

30 days

Results posted on

2017-04-18

Participant Flow

Participant milestones

Participant milestones
Measure
Negative Pressure Wound Therapy
After the completion of the operation, incisional skin closure was performed using sutures or staples and the wound was then covered with the Negative Pressure Wound therapy Prevena Incision Management System (Kinetic Concepts Inc) as per the manufacturer's instructions of use. Continuous negative pressure was applied at 125 mm Hg. For inpatients, wounds were assessed every 48 hours by inspection and palpation. The dressing was not routinely removed, but the surrounding skin was assessed for cellulitis. The NPWT dressing was removed between post-operative day 5 and 7.
Overall Study
STARTED
10
Overall Study
COMPLETED
10
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Treatment Group
n=10 Participants
Negative Pressure treatment
Age, Categorical
<=18 years
0 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
7 Participants
n=99 Participants
Age, Categorical
>=65 years
3 Participants
n=99 Participants
Age, Continuous
62.8 years
STANDARD_DEVIATION 10.8 • n=99 Participants
Sex: Female, Male
Female
5 Participants
n=99 Participants
Sex: Female, Male
Male
5 Participants
n=99 Participants
Region of Enrollment
United States
10 participants
n=99 Participants

PRIMARY outcome

Timeframe: 30 days

Incidence of SSIs within 1 month (4 weeks) from the index operation. SSI is defined by the Centers for Disease Control and Prevention's National Healthcare Surveillance Network

Outcome measures

Outcome measures
Measure
Treatment Group
n=10 Participants
Negative Pressure Wound Therapy (NPWT) to closed surgical incision
Number of Participants With Surgical Site Infections Within 1 Month (4 Weeks ) From Index Operation
1 Participants

SECONDARY outcome

Timeframe: 4 weeks

Secondary (composite) outcomes: 1. other non infectious abdominal wound complications, 2. damage to the skin caused by the dressing 3. need to end the treatment prior the discharge OR prior to 5 -7 post- operative days. 4. need for re-application of the system for any reason

Outcome measures

Outcome measures
Measure
Treatment Group
n=10 Participants
Negative Pressure Wound Therapy (NPWT) to closed surgical incision
Composite Secondary Outcomes of Non-infectious Abdominal Wound Complications, Damage to the Skin Caused by the Dressing, Need to End the Treatment Prior to Discharge or Prior to 5-7 Post-operative Days, and Need for Reapplication of the System.
0 Participants

Adverse Events

Treatment Group

Serious events: 1 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Treatment Group
n=10 participants at risk
Negative Pressure Wound Therapy (NPWT) to closed surgical incision
General disorders
death
10.0%
1/10 • Number of events 1

Other adverse events

Other adverse events
Measure
Treatment Group
n=10 participants at risk
Negative Pressure Wound Therapy (NPWT) to closed surgical incision
Renal and urinary disorders
urinary tract infection
10.0%
1/10 • Number of events 1
Infections and infestations
intra-abdominal abscess requiring percutaneous drainage
10.0%
1/10 • Number of events 1

Additional Information

Dr. Daniel Dante Yeh, Assistant Professor of Surgery

Massachusetts General Hospital

Phone: 6177248604

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place